| Members |
targetComponentId |
| Listed for hosp admission NOS |
Listed for admission to hospital |
| Listed for hosp admission NOS |
Listed for admission to hospital |
| Listed for other medical admis |
Listed for admission to hospital |
| Listed for other medical admis |
Listed for admission to hospital |
| Listed for other surgical admn |
Listed for General Surgery admission (finding) |
| Listed for other surgical admn |
Listed for General Surgery admission (finding) |
| Listeria murrayi |
Listeria grayi |
| Literary/artistic/sport NOS |
Literary/artistic/sports occupation |
| Literary/artistic/sport NOS |
Literary/artistic/sports occupation |
| lithiumcarbonat 300 mg tablet med modificeret udløsning |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| Lithium carbonate 300mg prolonged-release oral tablet |
Product containing only lithium carbonate in oral dose form (medicinal product form) |
| lithiummonitorering |
Monitoring of lithium therapy |
| Lithotripsy NOS |
Lithotripsy |
| Lithotripsy NOS |
Lithotripsy |
| Levendefødt med fødselsasfyksi, ikke nærmere specificeret |
Intrapartum fetal hypoxia |
| Livedoid vasculitis of lower limb due to varicose veins of lower limb |
Livedoid vasculopathy of lower limb due to varicose veins of lower limb (disorder) |
| Bevægelig skinne |
Dynamic splinting |
| fund vedr. leveren udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
| Leverabsces – bortset fra leverabsces forårsaget af amøbeinfektion |
Abscess of liver |
| Liver derivative complex 25.5mg injection |
Liver extract only product |
| leverderivatkompleks 25,5 mg/ml injektionsvæske, opløsning, ampul |
Liver extract only product |
| Liver disorder NOS |
Disease of liver |
| Liver disorder NOS |
Disease of liver |
| Leversygdom, ikke nærmere specificeret |
Disease of liver |
| Liver enzymes NOS |
Measurement of liver enzyme |
| Liver enzymes NOS |
Measurement of liver enzyme |
| Liver function tests NOS |
Hepatic function panel |
| Liver function tests NOS |
Hepatic function panel |
| Leveroperationer, ikke nærmere specificeret |
Operation on liver |
| Liver operations NOS |
Operation on liver |
| Liver soft tissue X-ray |
Plain X-ray of liver (procedure) |
| røntgenundersøgelse af bløddel i leveren |
Plain X-ray of liver (procedure) |
| Living on the street |
Homeless |
| Living organism |
Organism (organism) |
| Living organism category not applicable |
Organism (organism) |
| Living organism not assigned code in SNOMED |
Organism (organism) |
| Living organism not assigned to a scientific category |
Organism (organism) |
| Living organism not identified |
No living organism identified (finding) |
| Lloyd's syndrome |
Autoimmune polyendocrinopathy |
| Lobster - dietary |
Lobster (substance) |
| Lokal fremrykningslap |
Reconstruction using local advancement flap (procedure) |
| lokalanæstesi mhp. indgreb på øje |
Administration of anesthesia (procedure) |
| Lokalanæstetisk blokade af ingvinal herniorafi |
Administration of anesthesia (procedure) |
| Local convulsion |
An epileptic seizure originating within networks limited to one hemisphere. They may be discretely localised or more widely distributed. Focal seizures may originate in subcortical structures. |
| Local cyst of bone |
Bone cyst |
| Local fasciocutaneous flap NOS |
Local fasciocutaneous flap |
| Local fasciocutaneous flap to head or neck NEC |
Local fasciocutaneous flap |
| Local flap of skin to head or neck NEC |
Reconstruction with local flap |
| Local flap reconstruction by V-Y advancement - action |
Local flap reconstruction by advancement - action (qualifier value) |
| Local government officer NOS |
Local government officer |
| Local government officer NOS |
Local government officer |
| Local government top manager NOS |
Local government top manager (occupation) |
| Local government top manager NOS |
Local government top manager (occupation) |
| Local pedicle V-Y flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle island flap reconstruction - action |
Local flap reconstruction - action |
| Local sensory skin flap NEC |
Local sensory skin flap (procedure) |
| Local subcutaneous pedicle flap, myocutaneous NEC |
Reconstruction using local subcutaneous pedicle myocutaneous flap |
| Local subcutaneous pedicle island flap to head or neck NEC |
Reconstruction using local subcutaneous pedicle island flap |
| Local subcutaneous pedicle island flap, axial pattern NEC |
Reconstruction using local axial pattern subcutaneous pedicle island flap |
| Lokal subkutan stilket ølap, aksialt mønster, til hoved eller hals |
Reconstruction of skin using local subcutaneous pedicle island axial pattern skin flap (procedure) |
| Local subcutaneous pedicle island flap, fasciocutaneous NEC |
Reconstruction using local subcutaneous pedicle fasciocutaneous flap |
| Local subcutaneous pedicle island flap, random pattern NEC |
Reconstruction using local subcutaneous pedicle island random pattern flap (procedure) |
| lokal subkutan stilket ølap, random pattern, til hoved eller hals |
Reconstruction of skin using local subcutaneous pedicle island random pattern skin flap (procedure) |
| Local subcutaneous pedicle skin flap NOS |
Reconstruction of skin using local subcutaneous pedicle skin flap (procedure) |
| Local transposition flap, axial pattern NEC |
Local transposition flap - axial pattern |
| Local transposition flap, random pattern NEC |
Local transposition flap - random pattern |
| lokalisationsrelateret kryptogen epilepsi |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| Localization-related epilepsy |
An epileptic seizure originating within networks limited to one hemisphere. They may be discretely localised or more widely distributed. Focal seizures may originate in subcortical structures. |
| lokalisationsrelateret idiopatisk epilepsi |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| lokalisationsrelateret symptomgivende epilepsi |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| lokalisationsrelateret symptomgivende epilepsi med specifik præcipiterende faktor |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| lokalisationsrelateret (fokal) (partiel) idiopatisk epilepsi og epileptiske syndromer med lokalt indsættende anfald |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| Lokal adult parodontit |
Localized chronic periodontitis |
| Localized dermatitis caused by drug taken internally |
Localized dermatitis caused by substance taken via oral route (disorder) |
| Locked twins obstructing labor |
Interlocked twins |
| Locomotor training NOS |
Locomotor training |
| Locomotor training NOS |
Locomotor training |
| Locomotory aid NOS |
Mobility aid (physical object) |
| Locomotory aid NOS |
Mobility aid (physical object) |
| lomefloxacin 0,3 % øjendråber |
Lomefloxacin 3 mg/mL eye solution |
| Langvarigt atonisk anfald |
An epileptic seizure consisting of sudden loss or diminution of muscle tone without apparent preceding myoclonic or tonic event, lasting approximately one to two seconds, involving head, trunk, jaw, or limb musculature, regardless of whether focal, generalised, or unknown onset, and whether aware or with impaired awareness. |
| Long-acting thyroid stimulator |
Thyroid stimulating immunoglobulins |
| Loperamide 2mg oral lyophilisate tablet |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride 1mg/5mL conventional release oral syrup |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydrochlorid 1 mg/5 ml sukkerfri syrup |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| loperamidhydrochlorid 2 mg smeltetablet |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
| Lophortyx gambelii |
Callipepla gambelii (organism) |
| loracarbef 100 mg/5 ml oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| loracarbef 200 mg/5 ml oral suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
| loratadin 10 mg/10 ml syrup |
Loratadine 1 mg/mL oral solution |
| loratadin + pseudoephedrinsulfat 5 mg/120 mg tablet med modificeret udløsning |
Loratadine and pseudoephedrine only product in oral dose form |
| Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet |
Loratadine and pseudoephedrine only product in oral dose form |
| Lordose ved hoftesygdom |
Lordosis deformity of spine due to disorder of hip region |
| lordose ved skeletdysplasi |
Lordosis deformity of spine due to congenital skeletal dysplasia |
| lovastatin 10 mg tablet med modificeret udløsning |
Product containing only lovastatin in oral dose form (medicinal product form) |
FHIR